Gut-Heart Axis: The Role of Gut Microbiota and Metabolites in Heart Failure
Circulation Research · 23.05.2025 · 136 (11) · 1382-1406
DOI: 10.1161/circresaha.125.325516 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Circulation Research, erschienen am 23.05.2025. Verfasst von Matthew Snelson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hypertension Research Laboratory, Department of Pharmacology, Biomedical Discovery Institute, Faculty of Medicine, Nursing and Health Sciences (M.S.,…. Hauptthemen laut MEDLINE: Heart Failure, Gastrointestinal Microbiome, Gastrointestinal Tract. Die Arbeit wurde bisher 116-mal zitiert (Crossref) und nennt 290 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Heart failure is a global health issue with significant mortality and morbidity. There is increasing evidence that alterations in the gastrointestinal microbiome, gut epithelial permeability, and gastrointestinal disorders contribute to heart failure progression through various pathways, including systemic inflammation, metabolic dysregulation, and modulation of cardiac function. Moreover, several medications used to treat heart failure directly impact the microbiome. The relationship between the gastrointestinal tract and the heart is bidirectional, termed the gut-heart axis. It is increasingly understood that diet-derived microbial metabolites are key mechanistic drivers of the gut-heart axis. This includes, for example, trimethylamine N -oxide and short-chain fatty acids. This review discusses current insights into the interplay between heart failure, its associated risk factors, and the gut microbiome, focusing on key metabolic pathways, the role of dietary interventions, and the potential for gut-targeted therapies. Understanding these complex interactions could pave the way for novel strategies to mitigate heart failure progression and improve patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hypertension Research Laboratory, Department of Pharmacology, Biomedical Discovery Institute, Faculty of Medicine, Nursing and Health Sciences (M.S., R.R.M., F.Z.M.), Monash University, Melbourne, Australia.
- Victorian Heart Institute (M.S., R.R.M., F.Z.M.), Monash University, Melbourne, Australia.
- Department of Cardiovascular and Metabolic Sciences, Center for Microbiome and Human Health, Lerner Research Institute (C.-F.L., W.H.W.T.), Cleveland Clinic, OH.
- Charité-Universitätsmedizin, Berlin, Germany (L.M., S.K.F.).
- Max Delbrück Center for Molecular Medicine, Berlin, Germany (L.M., S.K.F.).
- Experimental and Clinical Research Center (ECRC), Berlin, Germany (L.M., S.K.F.).
ORCID-Profile: Matthew Snelson, Rikeish R Muralitharan, Chia-Feng Liu, Lajos Markó, Sofia K Forslund, Francine Z Marques, W H Wilson Tang
Förderung
- NHLBI NIH HHS
Zitieren
APA
Snelson, M., R Muralitharan, R., Liu, C. F., Markó, L., Forslund, S. K., Marques, F. Z., & Tang, W. H. W. (2025). Gut-Heart Axis: The Role of Gut Microbiota and Metabolites in Heart Failure. Circulation Research, 136(11), 1382-1406. https://doi.org/10.1161/circresaha.125.325516
Vancouver
Snelson M, R Muralitharan R, Liu CF, Markó L, Forslund SK, Marques FZ, et al. Gut-Heart Axis: The Role of Gut Microbiota and Metabolites in Heart Failure. Circulation Research. 2025;136(11):1382-1406. doi:10.1161/circresaha.125.325516
BibTeX
@article{Snelson2025,
author = {Snelson, Matthew and R Muralitharan, Rikeish and Liu, Chia-Feng and Markó, Lajos and Forslund, Sofia K and Marques, Francine Z and Tang, W H Wilson},
title = {Gut-Heart Axis: The Role of Gut Microbiota and Metabolites in Heart Failure},
journal = {Circulation Research},
year = {2025},
volume = {136},
number = {11},
pages = {1382--1406},
doi = {10.1161/circresaha.125.325516}
}
EUVIMED